派博傳思國(guó)際中心

標(biāo)題: Titlebook: Assessment of Cancer Screening; A Primer Pamela M. Marcus Book‘‘‘‘‘‘‘‘ 2022 National Institutes of Health, Cancer Control and Population Sc [打印本頁]

作者: purulent    時(shí)間: 2025-3-21 18:41
書目名稱Assessment of Cancer Screening影響因子(影響力)




書目名稱Assessment of Cancer Screening影響因子(影響力)學(xué)科排名




書目名稱Assessment of Cancer Screening網(wǎng)絡(luò)公開度




書目名稱Assessment of Cancer Screening網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Assessment of Cancer Screening被引頻次




書目名稱Assessment of Cancer Screening被引頻次學(xué)科排名




書目名稱Assessment of Cancer Screening年度引用




書目名稱Assessment of Cancer Screening年度引用學(xué)科排名




書目名稱Assessment of Cancer Screening讀者反饋




書目名稱Assessment of Cancer Screening讀者反饋學(xué)科排名





作者: SPECT    時(shí)間: 2025-3-21 22:40

作者: incontinence    時(shí)間: 2025-3-22 03:23

作者: 毀壞    時(shí)間: 2025-3-22 07:31
Foundations,ed screening programs and opportunistic screening are compared and their strengths and weaknesses are noted. The most frequently used metrics of benefit of cancer screening are presented along with arguments for and against their use. The reason why efficacy, the ability of cancer screening to lead
作者: tenosynovitis    時(shí)間: 2025-3-22 10:18
Population Measures: Definitions,ver, intermediate outcomes that clearly are not favorable are sufficient evidence that cancer screening will not reduce cause-specific mortality. Chapter 4 presents methods for calculating intermediate and definitive outcomes. Examples and figures are provided to assist in comprehension.
作者: 外觀    時(shí)間: 2025-3-22 16:30

作者: Blatant    時(shí)間: 2025-3-22 18:42

作者: affluent    時(shí)間: 2025-3-23 00:31
Polish Journalists in the 1980s to detection of cancer, and provide no evidence as to screening’s ability to reduce mortality. Performance measures are rarely considered sufficient evidence to implement cancer screening for the first time, though they have driven dissemination of tests that are thought to represent upgrades of es
作者: Commentary    時(shí)間: 2025-3-23 05:08
Polish Journalists in the 1980scribe characteristics of the detected cancers or experience after diagnosis. For that information, intermediate and definitive outcomes are used. Intermediate and definitive outcomes are called population measures because they incorporate the experience of all cancers, regardless of the method of de
作者: aerial    時(shí)間: 2025-3-23 06:51
Kent and Synecdochal Native Identity,ant or study researcher. Most RCTs comprise two groups, referred to as trial arms. The intervention arm receives the cancer screening regimen that is under intervention, while the control arm receives no intervention or the current standard of care. The control arm is treated as the counterfactual e
作者: Paradox    時(shí)間: 2025-3-23 13:13

作者: 闡明    時(shí)間: 2025-3-23 14:13

作者: conifer    時(shí)間: 2025-3-23 18:15

作者: 新陳代謝    時(shí)間: 2025-3-24 00:10
Lean Yu,Shouyang Wang,Kin Keung Laigreement as to the degree of its impact. There is general agreement, however, that cancer screening programs impact health care spending and availability of resources yet benefit only a few of those who are screened. There is less agreement regarding what constitutes benefit and harm, and even less
作者: CHASM    時(shí)間: 2025-3-24 03:29

作者: 形容詞詞尾    時(shí)間: 2025-3-24 08:23

作者: Oration    時(shí)間: 2025-3-24 13:56

作者: SLUMP    時(shí)間: 2025-3-24 17:10

作者: 花爭(zhēng)吵    時(shí)間: 2025-3-24 21:54
http://image.papertrans.cn/b/image/163372.jpg
作者: legislate    時(shí)間: 2025-3-25 00:17
Additional Considerations,ied in scope and fall into one of three categories: data interpretation, methodology, and policy. Number needed to screen, magnitude of overdiagnosis, and de-implementation are a few of the topics that are discussed in the chapter.
作者: 商品    時(shí)間: 2025-3-25 06:58

作者: Diuretic    時(shí)間: 2025-3-25 07:45

作者: dysphagia    時(shí)間: 2025-3-25 12:44
Closing Thoughts,regarding the acceptable ratio of harm to benefit. The predominant feeling among individuals in the general public is that cancer screening is important and worthwhile, an assumption that in reality is often tenuous. Appreciation of the material presented in this primer is key to making informed decisions about cancer screening practices.
作者: 凝乳    時(shí)間: 2025-3-25 17:46

作者: 嫻熟    時(shí)間: 2025-3-25 22:20

作者: 卵石    時(shí)間: 2025-3-26 00:46
Lean Yu,Shouyang Wang,Kin Keung Laivasive cancer. Chapters ., ., ., ., ., ., and . presented material with an eye towards early detection cancer screening. Chapter . revisits the previously presented material with an eye towards cancer prevention screening.
作者: Arthropathy    時(shí)間: 2025-3-26 06:29

作者: Glossy    時(shí)間: 2025-3-26 08:50
Polish Journalists in the 1980se calculated from sensitivity and false positive rate, are presented as well. Additional aspects of performance measures, including the role of disease prevalence in cancer screening test performance (in particular, the impact on positive predictive value), are discussed.
作者: Esophagitis    時(shí)間: 2025-3-26 14:15
Kent and Synecdochal Native Identity, minimizes the possibility of confounding. In the context of cancer screening, confounding occurs when a third factor is related to both screening activity and cause-specific mortality. Individual-level, cluster-level, and pragmatic RCTs are discussed in detail. Examples of each are provided.
作者: Neonatal    時(shí)間: 2025-3-26 19:11
Lean Yu,Shouyang Wang,Kin Keung Laiird factor is associated with both the cancer screening practice and cause-specific mortality, meaning that the third factor is not equally present among groups of individuals with different cancer screening practices and is not equally present among groups of individuals with different cancer outcomes.
作者: 斗爭(zhēng)    時(shí)間: 2025-3-26 22:40
Performance Measures,e calculated from sensitivity and false positive rate, are presented as well. Additional aspects of performance measures, including the role of disease prevalence in cancer screening test performance (in particular, the impact on positive predictive value), are discussed.
作者: overture    時(shí)間: 2025-3-27 01:21
Experimental Research Designs, minimizes the possibility of confounding. In the context of cancer screening, confounding occurs when a third factor is related to both screening activity and cause-specific mortality. Individual-level, cluster-level, and pragmatic RCTs are discussed in detail. Examples of each are provided.
作者: 自戀    時(shí)間: 2025-3-27 06:33

作者: trigger    時(shí)間: 2025-3-27 12:25

作者: cunning    時(shí)間: 2025-3-27 15:01

作者: Eructation    時(shí)間: 2025-3-27 19:17
Foundations,lear thinking, an open mind, and knowledge of a small set of foundational concepts, which are presented in this chapter. Cancer screening, the routine, periodic testing for signs of cancer among individuals who have no symptoms, is explained and its goals, at both an individual and population level,
作者: Desert    時(shí)間: 2025-3-27 22:01

作者: 貪婪地吃    時(shí)間: 2025-3-28 02:42

作者: blackout    時(shí)間: 2025-3-28 06:41

作者: 反省    時(shí)間: 2025-3-28 12:06

作者: Narrative    時(shí)間: 2025-3-28 17:18
Observational Research Designs,ls’ cancer screening practices, cancer outcomes, and other factors if needed. Because no regimens are dictated, an observational study can capture information about and evaluate a variety of cancer screening practices, including use of different tests or cancer screening regimens. Observational stud
作者: Organonitrile    時(shí)間: 2025-3-28 19:09

作者: 物質(zhì)    時(shí)間: 2025-3-29 02:08
Additional Considerations,ied in scope and fall into one of three categories: data interpretation, methodology, and policy. Number needed to screen, magnitude of overdiagnosis, and de-implementation are a few of the topics that are discussed in the chapter.
作者: forbid    時(shí)間: 2025-3-29 04:54

作者: Euphonious    時(shí)間: 2025-3-29 09:09

作者: 面包屑    時(shí)間: 2025-3-29 12:12
Applied Environmental Science and Engineering for a Sustainable Futurehttp://image.papertrans.cn/a/image/146909.jpg
作者: 誘拐    時(shí)間: 2025-3-29 18:28

作者: 根除    時(shí)間: 2025-3-29 21:34





歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
来安县| 沐川县| 黄石市| 琼海市| 松滋市| 东丰县| 衢州市| 台江县| 会昌县| 肇庆市| 炉霍县| 普格县| 崇仁县| 东源县| 文山县| 伽师县| 江口县| 崇义县| 娱乐| 盱眙县| 玉环县| 夹江县| 普兰县| 大方县| 阜城县| 师宗县| 尉氏县| 斗六市| 胶南市| 漾濞| 华容县| 达拉特旗| 建宁县| 大竹县| 神池县| 金门县| 开阳县| 巴马| 井陉县| 海宁市| 平昌县|